These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 30755224)
1. PRIMA-1 Mlakar V; Jurkovic Mlakar S; Lesne L; Marino D; Rathi KS; Maris JM; Ansari M; Gumy-Pause F J Exp Clin Cancer Res; 2019 Feb; 38(1):69. PubMed ID: 30755224 [TBL] [Abstract][Full Text] [Related]
2. PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance. Tessoulin B; Descamps G; Moreau P; Maïga S; Lodé L; Godon C; Marionneau-Lambot S; Oullier T; Le Gouill S; Amiot M; Pellat-Deceunynck C Blood; 2014 Sep; 124(10):1626-36. PubMed ID: 25006124 [TBL] [Abstract][Full Text] [Related]
3. Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53. Li Z; Xu X; Li Y; Zou K; Zhang Z; Xu X; Liao Y; Zhao X; Jiang W; Yu W; Guo W; Chen Y; Li Y; Chen M; Deng WG; Li L; Zou L Cell Physiol Biochem; 2018; 45(5):1772-1786. PubMed ID: 29495002 [TBL] [Abstract][Full Text] [Related]
4. PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53. Grellety T; Laroche-Clary A; Chaire V; Lagarde P; Chibon F; Neuville A; Italiano A BMC Cancer; 2015 Oct; 15():684. PubMed ID: 26463477 [TBL] [Abstract][Full Text] [Related]
5. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Yi JS; Sias-Garcia O; Nasholm N; Hu X; Iniguez AB; Hall MD; Davis M; Guha R; Moreno-Smith M; Barbieri E; Duong K; Koach J; Qi J; Bradner JE; Stegmaier K; Weiss WA; Gustafson WC Neoplasia; 2021 Jun; 23(6):624-633. PubMed ID: 34107377 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status. Patyka M; Sharifi Z; Petrecca K; Mansure J; Jean-Claude B; Sabri S Oncotarget; 2016 Sep; 7(37):60245-60269. PubMed ID: 27533246 [TBL] [Abstract][Full Text] [Related]
7. PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells. Yoshikawa N; Kajiyama H; Nakamura K; Utsumi F; Niimi K; Mitsui H; Sekiya R; Suzuki S; Shibata K; Callen D; Kikkawa F Oncol Rep; 2016 May; 35(5):2543-52. PubMed ID: 26986846 [TBL] [Abstract][Full Text] [Related]
8. PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa. Saha MN; Jiang H; Yang Y; Reece D; Chang H Mol Cancer Ther; 2013 Nov; 12(11):2331-41. PubMed ID: 24030633 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5. Kanamori Y; Finotti A; Di Magno L; Canettieri G; Tahara T; Timeus F; Greco A; Tirassa P; Gasparello J; Fino P; Di Liegro CM; Proia P; Schiera G; Di Liegro I; Gambari R; Agostinelli E Cells; 2021 Jul; 10(8):. PubMed ID: 34440719 [TBL] [Abstract][Full Text] [Related]
10. PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53. Zandi R; Selivanova G; Christensen CL; Gerds TA; Willumsen BM; Poulsen HS Clin Cancer Res; 2011 May; 17(9):2830-41. PubMed ID: 21415220 [TBL] [Abstract][Full Text] [Related]
11. Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours. Chen L; Esfandiari A; Reaves W; Vu A; Hogarty MD; Lunec J; Tweddle DA Int J Oncol; 2018 Mar; 52(3):967-977. PubMed ID: 29393340 [TBL] [Abstract][Full Text] [Related]
12. USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation. Le Clorennec C; Lee K; Huo Y; Zage PE Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762082 [TBL] [Abstract][Full Text] [Related]
18. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. Torres J; Regan PL; Edo R; Leonhardt P; Jeng EI; Rappaport EF; Ikegaki N; Tang XX Int J Oncol; 2010 Oct; 37(4):983-91. PubMed ID: 20811720 [TBL] [Abstract][Full Text] [Related]
19. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma. Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426 [TBL] [Abstract][Full Text] [Related]
20. Floros KV; Cai J; Jacob S; Kurupi R; Fairchild CK; Shende M; Coon CM; Powell KM; Belvin BR; Hu B; Puchalapalli M; Ramamoorthy S; Swift K; Lewis JP; Dozmorov MG; Glod J; Koblinski JE; Boikos SA; Faber AC Cancer Res; 2021 Apr; 81(7):1896-1908. PubMed ID: 33483374 [No Abstract] [Full Text] [Related] [Next] [New Search]